French scientists said on Tuesday that lack of a key brain protein was linked to Alzheimer’s, a finding that threw up a tempting target for drugs to fight the disease.
Neuroscience
Lifelong brain-stimulating habits linked to lower Alzheimer’s protein levels
A new study led by researchers at the University of California, Berkeley, provides even more reason for people to read a book or do a puzzle, and to make such activities a lifetime habit.
fMRI brain imaging illuminates magic mushrooms’ psychedelic effects
Brain scans of people under the influence of the psilocybin, the active ingredient in magic mushrooms, have given scientists the most detailed picture to date of how psychedelic drugs work. The findings of two studies being published in scientific journals this week identify areas of the brain where activity is suppressed by psilocybin and suggest that it helps people to experience memories more vividly.
Neuroscientists explore how longstanding conflict influences empathy for others
MIT postdoc Emile Bruneau has long been drawn to conflict — not as a participant, but an observer. In 1994, while doing volunteer work in South Africa, he witnessed firsthand the turmoil surrounding the fall of apartheid; during a 2001 trip to visit friends in Sri Lanka, he found himself in the midst of the violent conflict between the Tamil Tigers and the Sri Lankan military.
Transcriptional barcoding of retinal cells identifies disease target cells
(Medical Xpress) — By developing a large scale gene expression map for retinal cell types, FMI Neurobiologists have been able to identify the cells in the retina, where the genes causing retinal diseases specifically act. This narrows down the search for a better understanding of the diseases and opens up new avenues for therapeutic approaches.